Section Arrow
Quote
OKUR.NASDAQ
- OnKure Therapeutics Inc
Quotes are at least 15-min delayed:2024/10/31 22:18 EDT
Last
 17.28
-0.21 (-1.20%)
Day High 
17.76 
Prev. Close
17.49 
1-M High
19.9992 
Volume 
110.85K 
Bid
16.5
Ask
17.94
Day Low
16.5 
Open
17.46 
1-M Low
16.1 
Market Cap 
221.30M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 17.92 
20-SMA 18.22 
50-SMA 16.28 
52-W High 81.8 
52-W Low 9.801 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.68/-0.65
Enterprise Value
221.30M
Balance Sheet
Book Value Per Share
2.30
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ELABElevai Labs0.059-0.0339-36.49%-- 
AVTEAerovate Therapeutics2.46+0.27+12.33%-- 
ENSCEnsysce Biosciences0.5754-0.0629-9.85%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.1445-0.0099-6.41%-- 
GLYCGlycoMimetics0.4069-0.0496-10.87%-- 
Quotes are at least 15-min delayed：2024/10/31 22:18 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.